CVS Group plc Block Listing Interim Review and TVR Update (0974F)
13 Luglio 2021 - 1:40PM
UK Regulatory
TIDMCVSG
RNS Number : 0974F
CVS Group plc
13 July 2021
13 July 2021
CVS Group plc
("CVS" or the "Company")
Block Listing Interim Review and TVR Update
CVS, one of the UK's leading providers of integrated veterinary
services, makes the following notification pursuant to Schedule Six
of the AIM Rules for Companies regarding its existing block listing
arrangements:
Name of the company: CVS Group plc
Name of relevant scheme: CVS Group 2017-2020
SAYE sharesave scheme
-------------------------------------
Period of return: From: 11 January 2021 To: 11 July 2021
--------- ---------------- ---- -------------
Balance of unallotted
securities under scheme(s)
from previous return: 114,302
-------------------------------------
Plus: The amount by Nil
which the block scheme(s)
has been increased
since the date of the
last return (if any
increase has been applied
for):
-------------------------------------
Less: Number of securities
issued/allotted under
scheme(s) during period: 109,188
-------------------------------------
Equals: Balance under
scheme(s) not yet issued/allotted
at end of period: 5,114
-------------------------------------
Number and class of 114,302 ordinary shares
securities originally of 0.2p each admitted
listed and the date on 11 January 2021
of admission:
-------------------------------------
Total Voting Rights
The number of securities that have been issued during the block
listing review period stated above includes 10,365 new ordinary
shares issued as a result of the exercise of options by employees
under the Company's Save As You Earn (SAYE) 2021 scheme to date
during July.
Following the issue of these new ordinary shares, which rank
pari passu in all respects with the Company's existing ordinary
shares, the Company has a total issued share capital of 70,764,147
Ordinary Shares, each carrying one voting right. The Company holds
no ordinary shares in treasury and the total number of voting
rights is therefore 70,764,147.
This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required
to notify their interest, or a change to their interest, in the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
Contacts:
CVS Group Plc Tel: +44 1379 644 288
Michelle Barker, Company Secretary
Singer Capital Markets (Nominated Adviser & Broker) Tel: +44 20 7496 3000
Aubrey Powell/Jen Boorer/Rachel Hayes
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRBBGDRIXBDGBX
(END) Dow Jones Newswires
July 13, 2021 07:40 ET (11:40 GMT)
Grafico Azioni Cvs (LSE:CVSG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Cvs (LSE:CVSG)
Storico
Da Apr 2023 a Apr 2024